OtherAssessment of safety, tolerability, pharmacokinetics, and pharmacological effect of orally administered CORT125134: an adaptive, double-blind, randomized, placebo-controlled phase 1 clinical study.Hunt et al. • 2017 Clin Pharmacol Drug Dev. 2017 Oct 2. doi: 10.1002/cpdd.389. 28967708 October 25, 2018 https://corcept.com/wp-content/uploads/COR-logo.svg 0 0 imc@healthandcommerce.com https://corcept.com/wp-content/uploads/COR-logo.svg imc@healthandcommerce.com2018-10-25 00:00:002018-10-25 00:00:00Assessment of safety, tolerability, pharmacokinetics, and pharmacological effect of orally administered CORT125134: an adaptive, double-blind, randomized, placebo-controlled phase 1 clinical study.
